Cellbion Co., Ltd
Develops radiopharmaceuticals and radioligand therapies for oncology.
308430 | KO
Overview
Corporate Details
- ISIN(s):
- KR7308430008
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 종로구 대학로 103 서울대학교 암연구소 6층, 종로구
- Website:
- http://www.cellbion.co.kr
- Sector:
- Manufacturing
Description
Cellbion Co., Ltd. is a company engaged in the research, development, and commercialization of radiopharmaceuticals. It specializes in Radioligand Therapy (RLT), developing both therapeutic and diagnostic agents to address unmet medical needs, primarily in oncology. The company's pipeline features innovative treatments, including antibody-based approaches and radioactive probes for medical imaging. A key therapeutic candidate in its portfolio is Lu-177-DGUL. Cellbion's focus is on advancing the field of nuclear medicine through novel drug development.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-12 00:00 |
투자판단관련주요경영사항(임상시험계획승인신청등결정) (전이성 거세 저항성 전립선암 환자에서 Lutetium(177Lu) …
|
Korean | 12.6 KB | ||
| 2025-09-09 00:00 |
기업설명회(IR)개최
|
Korean | 6.8 KB | ||
| 2025-09-04 00:00 |
투자판단관련주요경영사항(임상시험결과) (표준요법에 실패한 전이성 거세저항성 전립선암 환자에서 Lu177DGUL의 국내 …
|
Korean | 16.8 KB | ||
| 2025-08-13 00:00 |
반기보고서 (2025.06)
|
Korean | 1.1 MB | ||
| 2025-06-23 00:00 |
투자판단관련주요경영사항(임상시험계획승인신청) (전이성 거세 저항성 전립선암 환자에서 Lutetium(177Lu) DGU…
|
Korean | 9.0 KB | ||
| 2025-05-13 00:00 |
분기보고서 (2025.03)
|
Korean | 1.1 MB | ||
| 2025-03-31 00:00 |
정기주주총회결과
|
Korean | 23.1 KB | ||
| 2025-03-31 00:00 |
주식매수선택권부여에관한신고
|
Korean | 15.3 KB | ||
| 2025-03-31 00:00 |
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 9.9 KB | ||
| 2025-03-20 00:00 |
사업보고서 (2024.12)
|
Korean | 460.8 KB | ||
| 2025-03-14 00:00 |
감사보고서제출
|
Korean | 18.9 KB | ||
| 2025-03-11 00:00 |
기업설명회(IR)개최
|
Korean | 6.8 KB | ||
| 2025-02-28 00:00 |
주주총회소집결의
|
Korean | 11.8 KB | ||
| 2025-02-28 00:00 |
주주총회소집공고
|
Korean | 119.1 KB | ||
| 2025-01-31 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.5 KB |
Automate Your Workflow. Get a real-time feed of all Cellbion Co., Ltd filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Cellbion Co., Ltd
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Cellbion Co., Ltd via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
